ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter

Jack Ma-backed Prenetics plots IPO after COVID-19 test success

Hong Kong startup enlists New World Development CEO as investor

An employee handles a sample at a laboratory of biotechnology start-up Prenetics in Hong Kong.    © AFP/Jiji

HONG KONG -- Prenetics, the Hong Kong-based COVID-19 test provider that helped English football's Premier League resume matches, is planning an initial public offering as early as this year and is on track to close a $100 million pre-IPO funding round in the first quarter, according to people familiar with the discussions.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more